Detalles de la búsqueda
1.
Pembrolizumab plus concurrent chemoradiotherapy versus placebo plus concurrent chemoradiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (KEYNOTE-412): a randomised, double-blind, phase 3 trial.
Lancet Oncol
; 25(5): 572-587, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38561010
2.
Locoregional treatment of primary tumor in synchronous metastatic head and neck squamous cell carcinomas.
Acta Oncol
; 62(5): 465-472, 2023 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-37151099
3.
Long-term results from a clinical study of xevinapant plus chemoradiotherapy in people with high-risk locally advanced squamous cell carcinoma of the head and neck: a plain language summary.
Future Oncol
; 19(26): 1769-1776, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-37439181
4.
Disease-free time stratification in locally recurrent head and neck carcinoma after definitive radiotherapy or chemoradiotherapy.
Eur Arch Otorhinolaryngol
; 279(6): 3063-3069, 2022 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-34648050
5.
Debio 1143 and high-dose cisplatin chemoradiotherapy in high-risk locoregionally advanced squamous cell carcinoma of the head and neck: a double-blind, multicentre, randomised, phase 2 study.
Lancet Oncol
; 21(9): 1173-1187, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32758455
6.
Pembrolizumab given concomitantly with chemoradiation and as maintenance therapy for locally advanced head and neck squamous cell carcinoma: KEYNOTE-412.
Future Oncol
; 16(18): 1235-1243, 2020 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-32490686
7.
CDK4/6 inhibitors in P16/HPV16-negative squamous cell carcinoma of the head and neck.
Eur Arch Otorhinolaryngol
; 277(5): 1273-1280, 2020 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-32162057
8.
Letter to the Editor: SMAC mimetics inhibit human T cell proliferation and fail to augment type 1 cytokine responses.
Cell Immunol
; 395-396: 104772, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-37996259
9.
Correlation between the duration of locoregional control and survival in T1-T2 oropharyngeal cancer patients.
Eur Arch Otorhinolaryngol
; 276(4): 1161-1166, 2019 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-30666440
10.
Relationship between the time to locoregional recurrence and survival in laryngeal squamous-cell carcinoma.
Eur Arch Otorhinolaryngol
; 274(5): 2267-2271, 2017 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-28185009
11.
Outcomes and prognostic factors for squamous cell carcinoma of the oral tongue in young adults: a single-institution case-matched analysis.
Eur Arch Otorhinolaryngol
; 274(3): 1683-1690, 2017 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-27933385
12.
Results and Survival of Locally Advanced AJCC 7th Edition T4a Laryngeal Squamous Cell Carcinoma Treated with Primary Total Laryngectomy and Postoperative Radiotherapy.
Ann Surg Oncol
; 23(8): 2596-601, 2016 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-27034080
13.
Sinonasal squamous cell carcinoma without clinical lymph node involvement : Which neck management is best?
Strahlenther Onkol
; 192(8): 537-44, 2016 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-27323752
14.
An imbalance in competing mortality favouring Debio 1143 - Authors' reply.
Lancet Oncol
; 21(11): e503, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-33152295
15.
Concurrent use of cisplatin or cetuximab with definitive radiotherapy for locally advanced head and neck squamous cell carcinomas.
Strahlenther Onkol
; 190(9): 823-31, 2014 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-24638267
16.
Feasibility of radiotherapy or chemoradiotherapy after taxane-based induction chemotherapy for nonoperated locally advanced head and neck squamous cell carcinomas.
Anticancer Drugs
; 25(10): 1220-6, 2014 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-25144345
17.
Nedaplatin in nasopharyngeal cancer: the rebirth of platinum salts?
Lancet Oncol
; 19(4): 429-431, 2018 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29501364
18.
A multicentric randomized controlled phase III trial of adaptive and 18F-FDG-PET-guided dose-redistribution in locally advanced head and neck squamous cell carcinoma (ARTFORCE).
Radiother Oncol
; 196: 110281, 2024 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-38636708
19.
Afatinib maintenance therapy following post-operative radiochemotherapy in head and neck squamous cell carcinoma: Results from the phase III randomised double-blind placebo-controlled study BIB2992ORL (GORTEC 2010-02).
Eur J Cancer
; 178: 114-127, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36434888
20.
Extended follow-up of a phase 2 trial of xevinapant plus chemoradiotherapy in high-risk locally advanced squamous cell carcinoma of the head and neck: a randomised clinical trial.
Eur J Cancer
; 183: 24-37, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36796234